title: Cell Salvage in Obstetrics.
abstract: Intraoperative cell salvage is a strategy to decrease the need for allogeneic blood transfusion. Traditionally, cell salvage has been avoided in the obstetric population because of the perceived risk of amniotic fluid embolism or induction of maternal alloimmunization. With advances in cell salvage technology, the risks of cell salvage in the obstetric population parallel those in the general population. Levels of fetal squamous cells in salvaged blood are comparable to those in maternal venous blood at the time of placental separation. No definite cases of amniotic fluid embolism have been reported and appear unlikely with modern equipment. Cell salvage is cost-effective in patients with predictably high rates of transfusion, such as parturients with abnormal placentation.
authors.affiliation: From the Department of Anesthesiology, Northwestern University, Chicago, Illinois.
authors.forename: Haley
authors.initials: H
authors.lastname: Goucher
authors.forename: Cynthia A
authors.initials: CA
authors.lastname: Wong
authors.forename: Samir K
authors.initials: SK
authors.lastname: Patel
authors.forename: Paloma
authors.initials: P
authors.lastname: Toledo
mesh_terms: D001804:Blood Transfusion, Autologous / Q000009:adverse effects; D002585:Cesarean Section / Q000009:adverse effects*; D004619:Embolism, Amniotic Fluid / Q000209:etiology; D005260:Female; D006801:Humans; D009774:Obstetrics / Q000379:methods*; D057725:Operative Blood Salvage / Q000009:adverse effects; D010922:Placenta Diseases / Q000209:etiology / Q000628:therapy; D006473:Postpartum Hemorrhage / Q000209:etiology / Q000628:therapy; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D012307:Risk Factors; D016896:Treatment Outcome